SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Oud, K T.M
Right arrow Articles by Jonkers, R E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oud, K T.M
Right arrow Articles by Jonkers, R E
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Lung Diseases
*Lupus
*Steroids
Hazardous Substances DB
*METHYLPREDNISOLONE
*PREDNISOLONE
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The shrinking lung syndrome in systemic lupus erythematosus: improvement with corticosteroid therapy

K T.M Oud

Pulmonology Department, Pulmonology Department, Onze Lieve Vrouwe Hospital, Amsterdam, The Netherlands

P Bresser

Pulmonology Department

R J M ten Berge

Department of Internal Medicine, Division of Clinical Immunology & Rheumatology, Academic Medical Centre, Amsterdam, The Netherlands

R E Jonkers

Pulmonology Department, r.e.jonkers{at}amc.uva.nl

Respiratory manifestations of systemic lupus erythematosus (SLE) are frequent. The ‘shrinking lung syndrome’ (SLS) represents a rare complication of SLE. The pathogenesis and therapy of the SLS remains controversial. We report a series of five consecutive cases with the SLS of which we provide a detailed description of the extent and dynamics of the response to corticosteroid therapy.

Key Words: corticosteroids • diaphragmatic weakness • shrinking lung syndrome • systemic lupus erythematosus

Lupus, Vol. 14, No. 12, 959-963 (2005)
DOI: 10.1191/0961203305lu2186cr
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Advertisement